VYNE Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch VYNE and buy or sell other stocks, ETFs, and their options commission-free!

About VYNE

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. 

CEO
David Domzalski
CEODavid Domzalski
Employees
28
Employees28
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2011
Founded2011
Employees
28
Employees28

VYNE Key Statistics

Market cap
151.47M
Market cap151.47M
Price-Earnings ratio
-0.33
Price-Earnings ratio-0.33
Dividend yield
—
Dividend yield—
Average volume
346.35K
Average volume346.35K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.79
52 Week high$0.79
52 Week low
$0.1107
52 Week low$0.1107

Stock Snapshot

VYNE Therapeutics(VYNE) stock is priced at $2.61, giving the company a market capitalization of 151.47M. It carries a P/E multiple of -0.33.

During the trading day, VYNE Therapeutics(VYNE) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 346.35K.

The stock's 52-week range extends from a low of $0.11 to a high of $0.79.

The stock's 52-week range extends from a low of $0.11 to a high of $0.79.

People also own

Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.